6 results
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
abstinent from short-acting ... margin of safety in pharmacology ... the sublingual tablet ... #Comparison #Table ... #Pharmacology #
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
Insulin and analogues ... #pharmacology #table ... #comparison #dosing ... #insulin #diabetes ... #medications #halflife
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... GLP-1 receptor agonist ... DM2 #Inpatient #Medications ... #pharmacology # ... comparison #table
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Buprenorphine - Comparison ... Table Some patients ... interested in medication ... 5-7 day for short ... Dosing usually begins
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
commonly used medications ... to treat Type 2 Diabetes ... of my previous posts ... #Pharmacology #Dosing ... #Diabetes #DM2
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
Dosing: 3 mg ... semaglutide, the same medication ... drug to remain stable ... #semaglutide #Diabetes ... #Pharmacology #